Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) came out with a quarterly loss of $0.20 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.27 per share when it actually produced a loss of $0.20, delivering a surprise of 25.93%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Exagen, which belongs to the Zacks Medical - ...